Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Avapena
2. Chloropyramine
3. Chloropyramine Monohydrochloride
4. Chlorpyramine
5. Halopyramine
6. N-(p-chlorobenzyl)-n-(2-pyridyl)-n',n''-dimethylethylenediamine
7. Suprastin
1. 6170-42-9
2. Chloropyramine Hcl
3. Alergosan
4. Nilfan
5. Halopyramine Hydrochloride
6. Chlorpyramine Hydrochloride
7. N1-(4-chlorobenzyl)-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diamine Hydrochloride
8. Allergan S Hydrochloride
9. Chlorpiramin Hydrochloride
10. Chlorpyramin Hcl
11. Chloropyribenzamine Hydrochloride
12. Fwa92z14nn
13. Mls000028842
14. Nsc-409949
15. Smr000058807
16. Dsstox_cid_28785
17. Dsstox_rid_83054
18. Dsstox_gsid_48859
19. Sinopen
20. N'-[(4-chlorophenyl)methyl]-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine;hydrochloride
21. 1,2-ethanediamine, N-((4-chlorophenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-, Monohydrochloride (9ci)
22. Sinopen Hydrochloride
23. Chloropyramine Monohydrochloride
24. Suprastin Hydrochloride
25. N-[(4-chlorophenyl)methyl]-n',n'-dimethyl-n-2-pyridinyl-1,2-ethanediamine
26. Sr-01000721869
27. Ncgc00016672-01
28. Ncgc00016672-04
29. Cas-6170-42-9
30. Unii-fwa92z14nn
31. Prestwick_999
32. Avapena (tn)
33. Einecs 228-216-2
34. Nsc 409949
35. N-p-chlorobenzyl-n',n'-dimethyl-n-2-pyridylethylenediamine Hydrochloride
36. Chlorpyramin Hydrochloride
37. Opera_id_1968
38. G 12144
39. Mls001077290
40. Mls002222287
41. Mls006010746
42. Schembl538104
43. Chembl550011
44. Dtxsid9048859
45. Hms1570b15
46. Pharmakon1600-01506064
47. Hy-b1305
48. Tox21_113349
49. Bdbm50015561
50. Mfcd00079009
51. Nsc409949
52. Nsc759320
53. S5670
54. Akos015961969
55. Tox21_113349_1
56. At25066
57. Ccg-213982
58. Cs-7974
59. H70c429
60. Ks-5156
61. Nsc-759320
62. Sb17058
63. N1-(4-chlorobenzyl)-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diaminehydrochloride
64. Chloropyramine Hydrochloride [mi]
65. 1,2-ethanediamine, N-((4-chlorophenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-, Monohydrochloride
66. Ac-12197
67. Chloropyramine Hydrochloride [mart.]
68. Db-053971
69. Chloropyramine Hydrochloride [who-dd]
70. Ft-0623695
71. D07679
72. Sr-01000721869-2
73. Sr-01000721869-3
74. W-105107
75. Q27278239
76. N-p-chlorobenzyl-n',n'-dimethyl-n-(2-pyridyl)ethylenediamine
77. 2-[p-chlorobenzyl-(2-dimethylaminoethyl)amino]pyridine Hydrochloride
78. Chloropyramine Hydrochloride, Analytical Standard, For Drug Analysis
79. 1, N-[(4-chlorophenyl)methyl]-n',n'-dimethyl-n-2-pyridinyl-, Monohydrochloride
80. N-(4-chlorobenzyl)-n'n'-dimethyl-n-(2-pyridyl) Ethylenediamine Hydrochloride
81. N\'-[(4-chlorophenyl)methyl]-n,n-dimethyl-n\'-pyridin-2-ylethane-1,2-diamine,hydrochloride
82. Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, Monohydrochloride
| Molecular Weight | 326.3 g/mol |
|---|---|
| Molecular Formula | C16H21Cl2N3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 6 |
| Exact Mass | 325.1112531 g/mol |
| Monoisotopic Mass | 325.1112531 g/mol |
| Topological Polar Surface Area | 19.4 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 264 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Chloropyramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chloropyramine, including repackagers and relabelers. The FDA regulates Chloropyramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chloropyramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chloropyramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chloropyramine supplier is an individual or a company that provides Chloropyramine active pharmaceutical ingredient (API) or Chloropyramine finished formulations upon request. The Chloropyramine suppliers may include Chloropyramine API manufacturers, exporters, distributors and traders.
click here to find a list of Chloropyramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chloropyramine written confirmation (Chloropyramine WC) is an official document issued by a regulatory agency to a Chloropyramine manufacturer, verifying that the manufacturing facility of a Chloropyramine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chloropyramine APIs or Chloropyramine finished pharmaceutical products to another nation, regulatory agencies frequently require a Chloropyramine WC (written confirmation) as part of the regulatory process.
click here to find a list of Chloropyramine suppliers with Written Confirmation (WC) on PharmaCompass.
Chloropyramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chloropyramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chloropyramine GMP manufacturer or Chloropyramine GMP API supplier for your needs.
A Chloropyramine CoA (Certificate of Analysis) is a formal document that attests to Chloropyramine's compliance with Chloropyramine specifications and serves as a tool for batch-level quality control.
Chloropyramine CoA mostly includes findings from lab analyses of a specific batch. For each Chloropyramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chloropyramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Chloropyramine EP), Chloropyramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chloropyramine USP).
LOOKING FOR A SUPPLIER?
